Key Financial’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305 Hold
25
– – ﹤0.01% 1255
2026
Q2
$446 Hold
25
– – ﹤0.01% 1273
2026
Q1
$228 Hold
25
– – ﹤0.01% 1341
2025
Q4
$342 Hold
25
– – ﹤0.01% 1347
2025
Q3
$523 Hold
25
– – ﹤0.01% 1331
2025
Q2
$298 Hold
25
– – ﹤0.01% 1366
2025
Q1
$297 Hold
25
– – ﹤0.01% 1326
2024
Q4
$384 Hold
25
– – ﹤0.01% 1309
2024
Q3
$280 Hold
25
– – ﹤0.01% 1299
2024
Q2
$135 Hold
25
– – ﹤0.01% 1306
2024
Q1
$170 Hold
25
– – ﹤0.01% 1273
2023
Q4
$170 Buy
+25
New +$142 ﹤0.01% 1282

Other funds holding CLPT

Key Financial's CLPT Position: Q3 2026 in Review

Key Financial held its ClearPoint Neuro (CLPT) position steady in Q3 2026 at 25 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Key Financial first reported a position in CLPT in Q4 2023 and has held it in 12 quarters since. The position peaked at $523 in Q3 2025. 89 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Key Financial held 25 shares of ClearPoint Neuro worth $305 as of Q3 2026.
  • Key Financial left its ClearPoint Neuro share count unchanged in Q3 2026.
  • ClearPoint Neuro made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1255 holding.
  • Key Financial first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 12 quarters since.
  • Key Financial's ClearPoint Neuro position peaked at $523 in Q3 2025.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.